Company news
Cipla Ltd (NSE:CIPLA) news
Every Cipla Ltd press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US
September 4, 2026
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in...
September 3, 2026
Cipla Ltd Press Release Aug 31 2026
August 31, 2026
Cipla Ltd Press Release Jul 23 2026
July 23, 2026
Press Release May 13 2026
May 13, 2026
Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin HFA
April 24, 2026
Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA
April 23, 2026
Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis
April 2, 2026
Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation
March 16, 2026
Cipla strengthens US portfolio with the launch of generic Saxenda(R) (Liraglutide Injection) for weight management therapy
March 2, 2026
Cipla strengthens US portfolio with the launch of generic Saxenda for weight management therapy
March 2, 2026
Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy
February 27, 2026
Press Release Jan 23 2026
January 23, 2026
Cipla USA Strengthens Lung Leadership with Community Wellness Initiatives
November 17, 2025
Press Release Oct 30 2025
October 30, 2025
Cipla Expands Fall River Operations in USA, Announces Upcoming Hiring for Various Roles
August 7, 2025
Press Release Jul 25 2025
July 25, 2025
Press Release May 13 2025
May 13, 2025
Press Release Jan 28 2025
January 28, 2025
Press Release Oct 29 2024
October 29, 2024
Press Release Jul 26 2024
July 26, 2024
Cipla : Orchid Pharma partners with Cipla to launch antibiotic Cefepime - Enmetazobactam in India
June 28, 2024
Cipla : signs a non-exclusive patent license agreement with Takeda to commercialize Vonoprazan drug in India
June 20, 2024
Cipla EU to invest an additional EUR 3 million in Ethris
June 19, 2024
Press Release Jun 18 2024
June 18, 2024
Cipla : announces additional investment in Achira
May 15, 2024
Press Release May 10 2024
May 10, 2024
Press Release Mar 26 2024
March 26, 2024
Press Release Jan 22 2024
January 22, 2024
Press Release Jan 08 2024
January 8, 2024
Press Release (Revised) Dec 15 2023
December 15, 2023
Press Release Dec 14 2023
December 14, 2023
Press Release Dec 10 2023
December 10, 2023
Cipla Ltd Press Release Dec 10 2023
December 9, 2023
Press Release Oct 27 2023
October 27, 2023
Press Release Sep 04 2023
September 4, 2023
Press Release Jul 26 2023
July 26, 2023
Press Release Jul 07 2023
July 7, 2023
Cipla Ltd Press Release Jul 07 2023
July 6, 2023
Press Release May 12 2023
May 12, 2023
Press Release Jan 25 2023
January 25, 2023
Press Release Jan 18 2023
January 18, 2023
Cipla Ltd Press Release Jan 18 2023
January 17, 2023
Press Release Dec 30 2022
December 30, 2022
Press Release Nov 29 2022
November 29, 2022
Press Release Nov 04 2022
November 4, 2022
Press Release Oct 11 2022
October 11, 2022
Press Release Sep 07 2022
September 7, 2022
Press Release Jul 29 2022
July 29, 2022
Press Release Jul 14 2022
July 14, 2022